L-Lactic Acid

L-Lactic Acid

SCHEMBL1865564

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].[NH4+].[NH4+].[Zr+4].[Zr+4]

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3

The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.50
TP53 P04637 1/20 0.42
CA4 P22748 4/20 0.37
CA2 P00918 1/20 0.33
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Lactic Acid SCHEMBL11430931 1.00 CA1 (0.50) CA1TP53CA4CA2LMNA
L-Lactic Acid SCHEMBL11443440 1.00 CA1 (0.50) CA1TP53CA4CA2LMNA
L-Lactic Acid SCHEMBL1741442 0.97 CA1 (0.53) CA1TP53CA4CA2CYP3A4
L-Lactic Acid SCHEMBL1865567 0.94 CA1 (0.50) CA1TP53CA4CA2LMNA
L-Lactic Acid SCHEMBL11443455 0.94 CA1 (0.50) CA1TP53CA4CA2CYP3A4
L-Lactic Acid SCHEMBL223994 0.94 TP53 (0.47) CA1TP53CA4CA2LMNA
L-Lactic Acid SCHEMBL2803173 0.94 TP53 (0.47) CA1TP53CA4CA2LMNA
L-Lactic Acid SCHEMBL1168923 0.90 CA1 (0.60) CA1TP53CA4CA2CYP3A4
L-Lactic Acid SCHEMBL5921228 0.90 CA1 (0.53) CA1TP53CA4CA2CYP3A4
L-Lactic Acid SCHEMBL1741444 0.90 CA1 (0.53) CA1TP53CA4CA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2494001-A1 WELL TREATMENT FLUIDS CONTAINING A VISCOELASTIC SURFACTANT AND A CROSS-LINKING AGENT COMPRISING A WATER-SOLUBLE TRANSITION METAL COMPLEX Halliburton Energy Services, Inc. (US) 2012-09-05 EP claimed
WO-2011051683-A1 WELL TREATMENT FLUIDS CONTAINING A VISCOELASTIC SURFACTANT AND A CROSS-LINKING AGENT COMPRISING A WATER-SOLUBLE TRANSITION METAL COMPLEX HALLIBURTON ENERGY SERVICES, INC. (US) 2011-05-05 WO claimed
US-20110105369-A1 WELL TREATMENT FLUIDS CONTAINING A VISCOELASTIC SURFACTANT AND A CROSS-LINKING AGENT COMPRISING A WATER-SOLUBLE TRANSITION METAL COMPLEX HALLIBURTON ENERGY SERVICES, INC. 2011-05-05 US claimed
EP-2494001-A1 WELL TREATMENT FLUIDS CONTAINING A VISCOELASTIC SURFACTANT AND A CROSS-LINKING AGENT COMPRISING A WATER-SOLUBLE TRANSITION METAL COMPLEX Halliburton Energy Services, Inc. (US) 2012-09-05 EP disclosed
WO-2011051683-A1 WELL TREATMENT FLUIDS CONTAINING A VISCOELASTIC SURFACTANT AND A CROSS-LINKING AGENT COMPRISING A WATER-SOLUBLE TRANSITION METAL COMPLEX HALLIBURTON ENERGY SERVICES, INC. (US) 2011-05-05 WO disclosed
US-20110105369-A1 WELL TREATMENT FLUIDS CONTAINING A VISCOELASTIC SURFACTANT AND A CROSS-LINKING AGENT COMPRISING A WATER-SOLUBLE TRANSITION METAL COMPLEX HALLIBURTON ENERGY SERVICES, INC. 2011-05-05 US disclosed